This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Mechanism for improvement in glycaemic control following bariatric surgery

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • diabetes remission results from improvements in both insulin resistance and beta-cell dysfunction, but the degree of their improvement also depends on the type of surgery performed (1,2,3,4,5)

  • restrictive procedure (LAGB) is thought to achieve glycemic control purely through weight loss without an entero-hormonal effect
    • therefore, the remission of diabetes is slow and occurs in parallel with gradual weight loss

  • the most investigated metabolic procedure is roux-en-Y gastric bypass (RYGB), which exhibits significant hormonal changes after surgery; the glycemic control is acute and immediate via an anti-diabetic weight-independent mechanism, even without significant weight loss after surgery
    • the magnitude of metabolic control is much greater than the expected degree of weight loss, which might be a clue that the altered hormonal milieu of gut-hormone release explains the metabolic disease control

Proposed mechanisms for improved glycaemic control secondary to bariatric surgery (apart from secondary to weight loss):

Foregut effect

  • 'foregut hypothesis' proposes that the exclusion of the duodenum and proximal jejunum from the transit of nutrients may prevent the secretion of a putative signal that promotes insulin resistance and T2DM, suggesting that a yet unidentified inhibitory product from the proximal bowel causes metabolic changes (anti-incretin)
    • hypothesis was based on an animal study by Rubino et al, which supported the foregut hypothesis as a dominant mechanism in improving glucose homeostasis after RYGB (1)

Hindgut effect

  • 'hindgut hypothesis' proposes that diabetes control results from the expedited delivery of nutrients to the distal bowel, thus producing a physiologic signal that improves glucose homeostasis
    • potential mediators of this effect are glucagon-like peptide-1 (GLP-1), GIP (incretin effect) and peptide YY (non-incretin)
    • rapid delivery of nutrients has been demonstrated to stimulate the 'L' cells in the distal intestine to secrete incretin, thus enhancing insulin secretion and insulin sensitivity
    • peptide YY is an anorexic hormone co-secreted with GLP-1 from intestinal L cells in response to nutrients
      • acts to decrease food intake due to faster satiation and may reduce insulin resistance
      • studies have shown the elevation of peptide YY together with GLP-1 in response to nutrients after RYGB, which is not observed after LAGB

Ghrelin effect

  • Ghrelin is an orexigenic gut hormone and has stimulatory effects on growth hormone release
    • mainly secreted from the gastric fundus and displays an ultradian rhythm with an increase before meals and a decrease after meals
      • ghrelin levels decrease dramatically in patients who have undergone RYGB
      • ghrelin is undoubtedly decreased after sleeve gastrectomy
      • ghrelin has also been shown to have diabetogenic effects because ghrelin administration in humans suppresses insulin secretion, even in the setting of ghrelin-induced hyperglycemia

Role of bile acid

  • bile acids are a key stimulus for the farnesoid X receptor in the liver, affecting hepatic metabolism and G-protein-coupled bile acid-activated receptors (TGR5) of the enteroendocrine L-cells and promoting the release of incretin
    • thus, bile acids play an important role in glucose homoeostasis
      • post-operative increases in circulating bile acids have been suggested to contribute to the metabolic benefits of bariatric surgery; however, their mechanisms remain undefined
      • clinical trials with the bile acid sequestrant colesevelam have shown its effectiveness in improving glycemic control in patients with T2DM
      • the re-route of nutrients due to altered physio-anatomy after gastric bypass may also affect the enterohepatic recirculation of bile acids and contribute to improved glycemic control

Reference:

  • Rubino F, Forgione A, Cummings DE, Vix M, Gnuli D, Mingrone G, Castagneto M, Marescaux J. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244:741-749.
  • Rubino F, Gagner M. Potential of surgery for curing type 2 diabetes mellitus. Ann Surg. 2002;236:554-559.
  • Lee WJ, Chong K, Chen CY, Chen SC, Lee YC, Ser KH, Chuang LM. Diabetes remission and insulin secretion after gastric bypass in patients with body mass index > 35 kg/m2. Obes Surg. 2011;21:889-895.
  • Arterburn DE, Courcoulas AP. Bariatric surgery for obesity and metabolic conditions in adults .BMJ. 2014 Aug 27;349

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.